Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v13-EN
Language French English
Date Updated 2021-02-18 2021-02-18
Drug Identification Number 02414201 02414201
Brand name AURO-VALSARTAN AURO-VALSARTAN
Common or Proper name Valsartan Valsartan
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients VALSARTAN VALSARTAN
Strength(s) 40MG 40MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 & 100 30 & 100
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-04-08 2020-04-08
Estimated end date 2021-02-28 2021-02-28
Actual end date 2021-02-17 2021-02-17
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Auro-Valsartan 40mg (100's) available as of February 17, 2021 Auro-Valsartan 40mg (30's) -Replaceable with Auro-Valsartan 40mg (100's) Auro-Valsartan 40mg (100's) available as of February 17, 2021 Auro-Valsartan 40mg (30's) -Replaceable with Auro-Valsartan 40mg (100's)
Health Canada comments